Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Methylprednisolone Sodium Succinate
Therapeutic Area : Immunology
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Dr. Reddy's Launches Generic Methylprednisolone Sodium Succinate for Injection in US
Details : Generic Methylprednisolone Sodium Succinate for injection, is the generic equivalent of Solumedrol, and has been approved by the U.S.FDA, indicated for various conditions including arthritis, blood disorders and severe allergic reactions.
Brand Name : Methylprednisolone Sodium Succinate-Generic
Molecule Type : Small molecule
Upfront Cash : Not Applicable
April 06, 2022
Lead Product(s) : Methylprednisolone Sodium Succinate
Therapeutic Area : Immunology
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?